Evinz Drugs Private Limited

Evinz Drugs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24230TG2002PTC040059 Incorporated 09 December 2002 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2020
₹24.63 Cr
▲ 5% YoY
Net profit · FY 2020
₹28.68 Lakh
Net margin 1.2%
EBITDA · FY 2020
₹1.11 Cr
EBITDA margin 4.5%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹41.38 Lakh
Issued & subscribed
Open charges
₹1.3 Cr
Secured borrowings
Company age
24 yrs
Est. 2002
Directors on board
2
As per MCA filings

About Evinz Drugs Private Limited

Data last updated:

Evinz Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 December 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2002PTC040059. Its GSTIN is 36AABCE1128P1ZK (Telangana).

The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹41.38 Lakh. It is led by directors Chapalamadugu Nitin and Eswar Chandra Vidya Sagar Magham.

Its last annual general meeting (AGM) was held on 29 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Plot No.622 Mathrusri Nagar Miyapur, Hyderabad, Telangana, India – 500049.

As per the financials filed for FY 2020, the company reported a revenue of ₹24.63 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹28.68 Lakh (net margin 1.2%) and EBITDA of ₹1.11 Cr (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 26% over five years.

As per MCA filings, the company has open charges of ₹1.3 Cr on record. Court records list 10 cases involving the company, including 3 filed by the company and 7 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230TG2002PTC040059
Registration Number 040059
Incorporation Date 09 December 2002
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Evinz Drugs has one previous CIN (Corporate Identification Number): U24230AP2002PTC040059. The current CIN is U24230TG2002PTC040059, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230TG2002PTC040059Current
U24230AP2002PTC040059Previous

Contact details

Evinz Drugs Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No.622 Mathrusri Nagar Miyapur, Hyderabad, Telangana, India – 500049
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Evinz Drugs Private Limited, buy the company report.

Comprehensive company report
Evinz Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Evinz Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Evinz Drugs Private Limited, buy the company report.

Financials of Evinz Drugs Private Limited

FY 2020 filings available

Evinz Drugs Private Limited reported revenue of ₹24.63 Cr (up 5% YoY) for FY 2020.

Revenue · FY 2020
₹24.63 Cr ▲ 5%
Net profit · FY 2020
₹28.68 Lakh margin 1.2%
EBITDA · FY 2020
₹1.11 Cr margin 4.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 28%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 47%
5 years · compounded
▲ 32%

Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 5% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations₹24.63 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.11 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹28.68 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin4.5%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Evinz Drugs Private Limited, buy the company report.

Board of directors of Evinz Drugs Private Limited

Evinz Drugs has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Eswar Chandra Vidya Sagar MaghamAdditional Director03 Apr 20179 Years 7 MonthsCurrent
Chapalamadugu NitinDirector04 Oct 201610 Years 1 MonthsCurrent

Peer comparison

Evinz Drugs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Brassica Pharma Private Limited₹24.78 Cr (FY 2025)-18.0%Mumbai, Maharashtra, India
Omni-Protech Drugs Private Limited₹24.63 Cr (FY 2025)4.0%Pune, Maharashtra, India
Evinz Drugs Private Limitedthis company₹24.63 Cr (FY 2020)₹28.68 Lakh1.2%5.0%Hyderabad, Telangana, India
Pharlink Labs Private Limited₹24.56 Cr (FY 2024)111.0%Chennai, Tamil Nadu, India
Remidex Pharma Private Limited₹24.56 Cr (FY 2025)-22.0%Bengaluru, Karnataka, India
Carewell Steuart Pharma Private Limited₹24.5 Cr (FY 2025)79.0%Tiruvallur, Tamil Nadu, India

To see the full peer comparison of Evinz Drugs Private Limited, buy the company report.

Auditor

Evinz Drugs Private Limited is audited by NAMBURU & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
NAMBURU & ASSOCIATESFY 2020012714S

Shareholding

The shareholding of Evinz Drugs Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Evinz Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.3 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹1.00 Cr
Andhra Bank₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Aug 2016100055735Others₹1 CrOpen
16 May 200610009611Andhra Bank₹30 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Evinz Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Evinz Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AABCE1128P1ZKTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Evinz Drugs Private Limited, buy the company report.

Recent activity

Evinz Drugs Private Limited has 13 board changes on record since 2012: 2 appointments and 11 cessations. The latest: Arepalli Babu Venkata Kishore ceased to be Director on 09 Feb 2018.

AGM
Evinz Drugs Private Limited last Annual general meeting of members was held on 29 Dec 2020 as per latest MCA records.
Filing
Evinz Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Ceased
Arepalli Babu Venkata Kishore ceased to be Director.
Appointed
Eswar Chandra Vidya Sagar Magham was appointed as Additional Director.
Appointed
Chapalamadugu Nitin was appointed as Director.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100055735 was registered on 09 Aug 2016.
Ceased
Raj Kumar Takkelapati ceased to be Director.
Ceased
Vijaya Bollu Lakshmi ceased to be Additional Director.
Ceased
Penumatsa Sarala Devi ceased to be Director.
Ceased
Chintalapati Rajesh Varma ceased to be Director.
Ceased
Bollu Vamsi Krishna ceased to be Director.
Ceased
Akinepalli Purushottam ceased to be Director.

6 earlier events are in the company report.

Frequently asked questions

Evinz Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 December 2002 (24+ years old) and is registered under CIN U24230TG2002PTC040059.

Evinz Drugs has 2 current directors:

The latest financial statements of Evinz Drugs on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 29 December 2020. Year-wise statements from 2015 are in the company report.

The GSTIN of Evinz Drugs is 36AABCE1128P1ZK, registered in Telangana.

The CIN (Corporate Identification Number) of Evinz Drugs is U24230TG2002PTC040059. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Evinz Drugs has 10 court cases on record: 3 filed by the company and 7 filed against it. Most are in the district courts.

Evinz Drugs was incorporated on 09 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Evinz Drugs by revenue are Brassica Pharma Private Limited, Omni-Protech Drugs Private Limited, Pharlink Labs Private Limited, Remidex Pharma Private Limited, Carewell Steuart Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Arepalli Babu Venkata Kishore ceased to be Director on 09 Feb 2018. Eswar Chandra Vidya Sagar Magham was appointed as Additional Director on 03 Apr 2017. Chapalamadugu Nitin was appointed as Director on 04 Oct 2016. Evinz Drugs has 13 board changes on record in total.

The registered office of Evinz Drugs is at Plot No.622 Mathrusri Nagar Miyapur, Hyderabad, Telangana, India – 500049.

Evinz Drugs operates in the pharma industry, in the drug formulation and development segment.